The U.S. Food and Drug Administration has approved Johnson & Johnson's (NYSE: JNJ) IMAAVY (nipocalimab-aahu) for the treatment of warm ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA